510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K931295Substantially Equivalent

Iq Tt4 Assay

Becton Dickinson Advanced Diagnostics, Sparks MD / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K931295 is the FDA 510(k) clearance record for IQ TT4 ASSAY, a class II device, cleared for Becton Dickinson Advanced Diagnostics on under FDA product code CDX (Radioimmunoassay, Total Thyroxine). FDA records list 10 510(k) clearances for Becton Dickinson Advanced Diagnostics, from to . As of , FDA records show no recalls naming K931295.

Clearance record

Decision date
Received
(127 days to decision)
Product code
CDX Radioimmunoassay, Total Thyroxine
Regulation
21 CFR 862.1700
Device class
Class II
Review panel
Clinical Chemistry
Applicant
Becton Dickinson Advanced Diagnostics 10 Loveton Cir., Sparks MD
510(k) summary
Summary
Third party review
No

Clearances, product code CDX

Trailing 12 months

FDA records hold no clearances under product code CDX in the trailing twelve months.

FDA records show no clearances under product code CDX in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code CDX, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260